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Wednesday, February 11, 2015 631aof CTCs in peripheral blood has been associated with the severity of the dis-
ease and have potential use for early detection, diagnosis, prognosis and treat-
ment monitoring. Nevertheless, their numbers are rare, typically less than one
to about a hundred cells in 1ml of blood. The isolation of CTCs using micro-
fluidics is attractive as the flow conditions can be accurately manipulated to
achieve an efficient separation. Here, we will demonstrate several effective
microfluidic separation methods by utilizing the unique biophysical property
differences such as size and deformability of cancer cells from that of blood
cells as well as exploiting the fluid dynamics in specially designed microflui-
dic channels to isolate the generally stiffer and larger CTCs from the more
deformable and smaller blood cells. Using this approach, we are able to
retrieve viable CTCs with high isolation efficiency and purity. With blood
specimens from cancer patients, we confirmed the successful detection, isola-
tion and retrieval of CTCs. Identification of CTCs will aid in the detection of
malignancy and disease as well as allow further insights into the metastatic
process.
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Chemotherapeutic and anticancer therapeutics face restricted usage at higher
concentrations, because of potential serious side effects on healthy cells. There-
fore, finding more effective delivery mechanisms may enhance the efficacy of
the compounds and decrease side effects. Recently, Magnetic Nanoparticles
(MNP) have been demonstrated to increase the performance of some anticancer
drugs. In the current study the effect of MNPs used in tandem with an anti-
cancer drug was studied on breast cancer cell lines with and without the effect
of external magnetic field.
MNP (functionalized and biocompatible Fe3O4 NPs 160 nm diameter) was
coupled with Doxorubicin (DOX), a commonly used anti-breast cancer drug,
and magnetically delivered to T47D breast cancer cells. Control studies were
performed with the intrinsic MNP and it was observed that they are not toxic
to the cells. 50% cell viability was observed with a 1 mg/ml concentration of
DOX and this concentration was further used for MNP studies. TheMNPs com-
bined with DOXwere magnetically delivered to the cancer cells, both as a func-
tion of time and magnetic field. Optical and Atomic Force Microscope (AFM)
were used to study the effect of these external parameters on the MNP penetra-
tion into the cell. From these microscopy studies. It was observed that more
MNP entered the cells with increasing time and magnetic field until a saturation
point was reached. Also it was observed that there was a 20% increase in cell
mortality for the cells treated with DOX l MNPs. This study was then modelled
with variable permeability medium and thus an optimum value of the time and
magnetic field was obtained.
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We report the development of a novel therapeutic nanoplatform, Targeted
Chemotherapeutic Nanoparticles (T-CNPs), for the diagnosis and treatment
of cancer. The T-CNPs are composed of iron oxide NPs that are functionalized
with water-soluble organic nanocontainers - for the encapsulation of a
combination of hydrophobic and/or hydrophilic drugs that can act synergisti-
cally - and conjugated to cell-penetrating peptides (CPPs) to enhance specific
targeting of tumors and internalization into cancer cells. The nanoplatform is
designed to simultaneously target a tumor, monitor it by magnetic resonance
imaging (MRI), and treat the disease by controlling the gradual release of the
delivered anti-cancer drugs using a non-invasive external stimulus, which
will concurrently induce hyperthermia. We will highlight new ways for the
active release of encapsulated drugs, particularly by an external magnetic field,
and promote the understanding of complex in vivo phenomenon when the
molecules are optimally delivered. The nanoplatform combines stability,
biocompatibility, and dual-purpose functionality (tumor treatment and imag-
ing), with multiple therapeutic strategies (targeted drug delivery and hyperther-
mia). Our system therefore consolidates diagnosis and targeted therapy into
a single, centralized system of treatment. This novel ‘theranostic’ strategy
has the potential to pave the way for treatment of cancer in a highly selective
and effective, yet relatively sensitive, manner.Engineered Biosurfaces
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Protein-protein interaction in live cell membranes can be shown by labelling
the proteins of interest and mapping the distribution of the respective fluores-
cent signal in the membrane. Colocalization analysis of the images can indicate
affinity of whatever kind, however background fluorescence, the excess of one
interaction partner, coincidental overlaps and the difficulties of multicolor-
imaging limit applicability and sensitivity of the approach. We presented a
method to circumvent many of the difficulties by arranging one of the proteins
as bait in a well-defined pattern in the cell membrane and measuring and
comparing the abundance and diffusion characteristics of the second protein
in bait-rich and bait-depleted areas and tested it on proteins of the immunolog-
ical synapse as we showed the recruitment of Lck to CD4-enriched areas. To
create those patterns the bait protein is immobilized by antibodies that are
linked to Streptavidin, which is deposited in an underlying structure using
soft lithography. The standard protocols for this technique allow only the cre-
ation of feature sizes which are at least one order of magnitude larger than the
supposed size of functional domains in the cell membrane. To miniaturize the
size of patterns to widths of 200nm and below great efforts in lithography are
required as substrates have to be chosen more carefully and novel stamp mate-
rials such as polyhedral oligomeric silsesquioxane, which contain custom
tailored functional groups, have to be used to achieve optimal stiffness control.
The characterization of the imprints using combined AFM and fluorescence
microscopy reveals a large environmental influence (humidity, temperature)
during deposition of proteins and storage on the quality of the imprint and
the substrate -protein binding affinity. We further investigate the micro- and
nanoscale homogeneity of deposited streptavidin and demonstrate the usage
of the miniaturized platform as a protein-protein interaction assay.
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Midbody, an organelle forming during cytokinesis, plays a pivotal role in the
final step of mitosis via recruitment of proteins and regulation of vesicle fusion.
Recently, many studies are emerging to reveal the molecular mechanism for the
functions of midbody-located proteins in cellular bridge abscission. Here, we
aim to resolve the morphology and infrastructure of midbody to understand
its role in cytokinesis. To achieve this goal, we apply super-resolution fluores-
cence imaging and atomic force microscopy (AFM) to uncover the relationship
between midbody structure and functions. We focus our attention on central-
spindlin, a tetramer composed of two MKLP1 and two MgcRacGAP, which
is critical for midbody formation. We found that microtubule-associated pro-
tein MKLP1 is a ring-like structure, the length and width of which is about
1.5 micron and 1 micron, respectively. Midbody height acquired by AFM is
about 700 nanometer. The petal-like protrusions on the top of midbody exhibit
large rigidity as high as 500kPa. Interestingly, AFM results show that midbody
is an asymmetric, palm-wrapping-fist structure. We speculate that the asym-
metric structure may be responsible for the asymmetric abscission during
cytokinesis.
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The immune recognition process involves an elaborate arrangement of adhe-
sion, costimulatory and signaling molecules organized into a stereotypic
geometric structure known as the immunological synapse (IS). We have
developed a versatile engineered platform to probe the minimum geometric
requirements (in terms of spacing and stoichiometry) for T-cell stimulation.
Arrays of metallic nanodots, ~ 2-10 nm in size, to which a UCHT1 Fab anti-
body was bound, were created by nanolithography. These served as individual
T-cell receptor (TCR) binding sites. The adhesion molecule ICAM-1 was
either statically bound to a PEG-silane brush surrounding the nanodots, or
